ID   MP2K5_HUMAN             Reviewed;         448 AA.
AC   Q13163; B4DE43; Q92961; Q92962;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   28-NOV-2006, sequence version 2.
DT   15-MAR-2017, entry version 174.
DE   RecName: Full=Dual specificity mitogen-activated protein kinase kinase 5;
DE            Short=MAP kinase kinase 5;
DE            Short=MAPKK 5;
DE            EC=2.7.12.2;
DE   AltName: Full=MAPK/ERK kinase 5;
DE            Short=MEK 5;
GN   Name=MAP2K5; Synonyms=MEK5, MKK5, PRKMK5;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A), FUNCTION, INTERACTION WITH
RP   ERK5 AND MAPK7, MUTAGENESIS OF LYS-195; SER-311 AND THR-315, AND
RP   PHOSPHORYLATION AT SER-311 AND THR-315.
RC   TISSUE=Fetal brain;
RX   PubMed=7759517; DOI=10.1074/jbc.270.21.12665;
RA   Zhou G., Bao Z.Q., Dixon J.E.;
RT   "Components of a new human protein kinase signal transduction
RT   pathway.";
RL   J. Biol. Chem. 270:12665-12669(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS B AND C), AND FUNCTION.
RC   TISSUE=Placenta;
RX   PubMed=9384584; DOI=10.1093/emboj/16.23.7054;
RA   Kato Y., Kravchenko V.V., Tapping R.I., Han J., Ulevitch R.J.,
RA   Lee J.-D.;
RT   "BMK1/ERK5 regulates serum-induced early gene expression through
RT   transcription factor MEF2C.";
RL   EMBO J. 16:7054-7066(1997).
RN   [3]
RP   SEQUENCE REVISION TO C-TERMINUS OF ISOFORM C.
RA   Lee J.D.;
RL   Submitted (MAY-2007) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM B).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM B).
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S.,
RA   Neubert P., Kstrang K., Schatten R., Shen B., Henze S., Mar W.,
RA   Korn B., Zuo D., Hu Y., LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM B).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   INTERACTION WITH YOPJ, AND ACETYLATION.
RX   PubMed=16728640; DOI=10.1126/science.1126867;
RA   Mukherjee S., Keitany G., Li Y., Wang Y., Ball H.L., Goldsmith E.J.,
RA   Orth K.;
RT   "Yersinia YopJ acetylates and inhibits kinase activation by blocking
RT   phosphorylation.";
RL   Science 312:1211-1214(2006).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-311, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 4-108 IN COMPLEX WITH
RP   MAP3K2.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of the complex of human mitogen activated protein
RT   kinase kinase 5 phox domain (MAP2K5-Phox) with human mitogen activated
RT   protein kinase kinase kinase 3 (MAP3K2B-Phox).";
RL   Submitted (NOV-2006) to the PDB data bank.
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.83 ANGSTROMS) OF 4-108 IN COMPLEX WITH
RP   MAP3K3.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of the complex of human mitogen activated protein
RT   kinase kinase 5 phox domain (MAP2K5-Phox) with human mitogen activated
RT   protein kinase kinase kinase 3 (MAP3K3B-Phox).";
RL   Submitted (NOV-2006) to the PDB data bank.
RN   [14]
RP   VARIANTS [LARGE SCALE ANALYSIS] ARG-118; VAL-427 AND THR-428.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Acts as a scaffold for the formation of a ternary
CC       MAP3K2/MAP3K3-MAP3K5-MAPK7 signaling complex. Activation of this
CC       pathway appears to play a critical role in protecting cells from
CC       stress-induced apoptosis, neuronal survival and cardiac
CC       development and angiogenesis. {ECO:0000269|PubMed:7759517,
CC       ECO:0000269|PubMed:9384584}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- SUBUNIT: Interacts with PARD6A, MAP3K3 and MAPK7. Forms a complex
CC       with SQSTM1 and PRKCZ or PRKCI (By similarity). Interacts with
CC       Yersinia yopJ. {ECO:0000250, ECO:0000269|PubMed:16728640,
CC       ECO:0000269|PubMed:7759517, ECO:0000269|Ref.12,
CC       ECO:0000269|Ref.13}.
CC   -!- INTERACTION:
CC       P62993:GRB2; NbExp=2; IntAct=EBI-307294, EBI-401755;
CC       Q99759:MAP3K3; NbExp=2; IntAct=EBI-307294, EBI-307281;
CC       Q13164:MAPK7; NbExp=4; IntAct=EBI-307294, EBI-1213983;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=B;
CC         IsoId=Q13163-1; Sequence=Displayed;
CC       Name=A;
CC         IsoId=Q13163-2; Sequence=VSP_021825;
CC       Name=C;
CC         IsoId=Q13163-3; Sequence=VSP_021825, VSP_021826;
CC         Note=Incomplete sequence.;
CC       Name=4;
CC         IsoId=Q13163-4; Sequence=VSP_043333;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in many adult tissues. Abundant in
CC       heart and skeletal muscle.
CC   -!- DOMAIN: Binds MAP3K2/MAP3K3 and MAPK7 via non-overlapping residues
CC       of the PB1 domain. This domain also mediates interactions with
CC       SQSTM1 and PARD6A (By similarity). {ECO:0000250}.
CC   -!- PTM: Activated by phosphorylation on Ser/Thr by MAP kinase kinase
CC       kinases. {ECO:0000250}.
CC   -!- PTM: Yersinia yopJ may acetylate Ser/Thr residues, preventing
CC       phosphorylation and activation, thus blocking the MAPK signaling
CC       pathway. {ECO:0000269|PubMed:16728640,
CC       ECO:0000269|PubMed:7759517}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. MAP kinase kinase subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U25265; AAA96146.1; -; mRNA.
DR   EMBL; U71087; AAB16851.1; -; mRNA.
DR   EMBL; U71088; AAB16852.2; -; mRNA.
DR   EMBL; BT006780; AAP35426.1; -; mRNA.
DR   EMBL; AK293459; BAG56954.1; -; mRNA.
DR   EMBL; CR542229; CAG47025.1; -; mRNA.
DR   EMBL; AC009292; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC016355; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC103753; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC008838; AAH08838.1; -; mRNA.
DR   CCDS; CCDS10224.1; -. [Q13163-1]
DR   CCDS; CCDS42051.1; -. [Q13163-2]
DR   CCDS; CCDS55970.1; -. [Q13163-4]
DR   RefSeq; NP_001193733.1; NM_001206804.1. [Q13163-4]
DR   RefSeq; NP_002748.1; NM_002757.3. [Q13163-2]
DR   RefSeq; NP_660143.1; NM_145160.2. [Q13163-1]
DR   UniGene; Hs.114198; -.
DR   PDB; 2NPT; X-ray; 1.75 A; A/C=5-108.
DR   PDB; 2O2V; X-ray; 1.83 A; A=5-108.
DR   PDB; 4IC7; X-ray; 2.60 A; B/E=16-130.
DR   PDBsum; 2NPT; -.
DR   PDBsum; 2O2V; -.
DR   PDBsum; 4IC7; -.
DR   ProteinModelPortal; Q13163; -.
DR   SMR; Q13163; -.
DR   BioGrid; 111593; 24.
DR   DIP; DIP-27558N; -.
DR   IntAct; Q13163; 17.
DR   MINT; MINT-1155433; -.
DR   STRING; 9606.ENSP00000178640; -.
DR   BindingDB; Q13163; -.
DR   ChEMBL; CHEMBL4948; -.
DR   GuidetoPHARMACOLOGY; 2066; -.
DR   iPTMnet; Q13163; -.
DR   PhosphoSitePlus; Q13163; -.
DR   BioMuta; MAP2K5; -.
DR   DMDM; 118572669; -.
DR   EPD; Q13163; -.
DR   MaxQB; Q13163; -.
DR   PaxDb; Q13163; -.
DR   PeptideAtlas; Q13163; -.
DR   PRIDE; Q13163; -.
DR   DNASU; 5607; -.
DR   Ensembl; ENST00000178640; ENSP00000178640; ENSG00000137764. [Q13163-1]
DR   Ensembl; ENST00000354498; ENSP00000346493; ENSG00000137764. [Q13163-4]
DR   Ensembl; ENST00000395476; ENSP00000378859; ENSG00000137764. [Q13163-2]
DR   GeneID; 5607; -.
DR   KEGG; hsa:5607; -.
DR   UCSC; uc002aqu.4; human. [Q13163-1]
DR   CTD; 5607; -.
DR   DisGeNET; 5607; -.
DR   GeneCards; MAP2K5; -.
DR   HGNC; HGNC:6845; MAP2K5.
DR   HPA; CAB022094; -.
DR   HPA; HPA027347; -.
DR   HPA; HPA027755; -.
DR   MIM; 602520; gene.
DR   neXtProt; NX_Q13163; -.
DR   OpenTargets; ENSG00000137764; -.
DR   PharmGKB; PA30590; -.
DR   eggNOG; KOG0581; Eukaryota.
DR   eggNOG; ENOG410XQ5A; LUCA.
DR   GeneTree; ENSGT00760000119199; -.
DR   HOGENOM; HOG000234206; -.
DR   HOVERGEN; HBG108518; -.
DR   InParanoid; Q13163; -.
DR   KO; K04463; -.
DR   OMA; EVVSMWV; -.
DR   OrthoDB; EOG091G06I7; -.
DR   PhylomeDB; Q13163; -.
DR   TreeFam; TF106468; -.
DR   BRENDA; 2.7.12.2; 2681.
DR   Reactome; R-HSA-198765; Signalling to ERK5.
DR   SignaLink; Q13163; -.
DR   SIGNOR; Q13163; -.
DR   ChiTaRS; MAP2K5; human.
DR   EvolutionaryTrace; Q13163; -.
DR   GeneWiki; MAP2K5; -.
DR   GenomeRNAi; 5607; -.
DR   PRO; PR:Q13163; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000137764; -.
DR   CleanEx; HS_MAP2K5; -.
DR   ExpressionAtlas; Q13163; baseline and differential.
DR   Genevisible; Q13163; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0005819; C:spindle; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; TAS:ProtInc.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0004702; F:signal transducer, downstream of receptor, with serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0000187; P:activation of MAPK activity; ISS:BHF-UCL.
DR   GO; GO:0071363; P:cellular response to growth factor stimulus; ISS:BHF-UCL.
DR   GO; GO:0071499; P:cellular response to laminar fluid shear stress; TAS:BHF-UCL.
DR   GO; GO:0070375; P:ERK5 cascade; IEA:Ensembl.
DR   GO; GO:0007507; P:heart development; IEA:Ensembl.
DR   GO; GO:0090051; P:negative regulation of cell migration involved in sprouting angiogenesis; ISS:BHF-UCL.
DR   GO; GO:2000342; P:negative regulation of chemokine (C-X-C motif) ligand 2 production; ISS:BHF-UCL.
DR   GO; GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; ISS:BHF-UCL.
DR   GO; GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; ISS:BHF-UCL.
DR   GO; GO:0034115; P:negative regulation of heterotypic cell-cell adhesion; ISS:BHF-UCL.
DR   GO; GO:0045415; P:negative regulation of interleukin-8 biosynthetic process; ISS:BHF-UCL.
DR   GO; GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; ISS:BHF-UCL.
DR   GO; GO:0060761; P:negative regulation of response to cytokine stimulus; ISS:BHF-UCL.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL.
DR   GO; GO:0030307; P:positive regulation of cell growth; IEA:Ensembl.
DR   GO; GO:0050679; P:positive regulation of epithelial cell proliferation; IEA:Ensembl.
DR   GO; GO:0051247; P:positive regulation of protein metabolic process; ISS:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription from RNA polymerase II promoter; ISS:BHF-UCL.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000270; PB1_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00564; PB1; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00666; PB1; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51745; PB1; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Complete proteome; Kinase; Magnesium; Metal-binding;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase; Tyrosine-protein kinase.
FT   CHAIN         1    448       Dual specificity mitogen-activated
FT                                protein kinase kinase 5.
FT                                /FTId=PRO_0000086383.
FT   DOMAIN       18    109       PB1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU01081}.
FT   DOMAIN      166    409       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     172    180       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   REGION       18     25       Interaction with MAPK7. {ECO:0000250}.
FT   REGION       64     68       Interaction with MAP3K2/MAP3K3.
FT                                {ECO:0000250}.
FT   REGION      117    131       Interaction with MAPK7. {ECO:0000250}.
FT   ACT_SITE    283    283       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING     195    195       ATP.
FT   MOD_RES     311    311       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195,
FT                                ECO:0000269|PubMed:7759517}.
FT   MOD_RES     315    315       Phosphothreonine.
FT                                {ECO:0000269|PubMed:7759517}.
FT   VAR_SEQ       1     45       MLWLALGPFPAMENQVLVIRIKIPNSGAVDWTVHSGPQLLF
FT                                RDVL -> MMEGHFPQS (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_043333.
FT   VAR_SEQ     349    358       Missing (in isoform A and isoform C).
FT                                {ECO:0000303|PubMed:7759517,
FT                                ECO:0000303|PubMed:9384584}.
FT                                /FTId=VSP_021825.
FT   VAR_SEQ     444    448       QQGPP -> LASLPSPSPSV (in isoform C).
FT                                {ECO:0000303|PubMed:9384584}.
FT                                /FTId=VSP_021826.
FT   VARIANT     118    118       H -> R (in dbSNP:rs56241934).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040823.
FT   VARIANT     427    427       A -> V. {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_040824.
FT   VARIANT     428    428       A -> T (in dbSNP:rs55811347).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_046070.
FT   MUTAGEN     195    195       K->M: Inactivation.
FT                                {ECO:0000269|PubMed:7759517}.
FT   MUTAGEN     311    311       S->A: Inactivation.
FT                                {ECO:0000269|PubMed:7759517}.
FT   MUTAGEN     315    315       T->A: Inactivation.
FT                                {ECO:0000269|PubMed:7759517}.
FT   STRAND       17     23       {ECO:0000244|PDB:2NPT}.
FT   TURN         24     26       {ECO:0000244|PDB:2NPT}.
FT   STRAND       27     33       {ECO:0000244|PDB:2NPT}.
FT   HELIX        41     51       {ECO:0000244|PDB:2NPT}.
FT   STRAND       58     63       {ECO:0000244|PDB:2NPT}.
FT   STRAND       65     67       {ECO:0000244|PDB:4IC7}.
FT   STRAND       69     72       {ECO:0000244|PDB:2NPT}.
FT   HELIX        75     93       {ECO:0000244|PDB:2NPT}.
FT   TURN         94     96       {ECO:0000244|PDB:2NPT}.
FT   STRAND      102    107       {ECO:0000244|PDB:2NPT}.
SQ   SEQUENCE   448 AA;  50112 MW;  F23BB327E2A9C7DC CRC64;
     MLWLALGPFP AMENQVLVIR IKIPNSGAVD WTVHSGPQLL FRDVLDVIGQ VLPEATTTAF
     EYEDEDGDRI TVRSDEEMKA MLSYYYSTVM EQQVNGQLIE PLQIFPRACK PPGERNIHGL
     KVNTRAGPSQ HSSPAVSDSL PSNSLKKSSA ELKKILANGQ MNEQDIRYRD TLGHGNGGTV
     YKAYHVPSGK ILAVKVILLD ITLELQKQIM SELEILYKCD SSYIIGFYGA FFVENRISIC
     TEFMDGGSLD VYRKMPEHVL GRIAVAVVKG LTYLWSLKIL HRDVKPSNML VNTRGQVKLC
     DFGVSTQLVN SIAKTYVGTN AYMAPERISG EQYGIHSDVW SLGISFMELA LGRFPYPQIQ
     KNQGSLMPLQ LLQCIVDEDS PVLPVGEFSE PFVHFITQCM RKQPKERPAP EELMGHPFIV
     QFNDGNAAVV SMWVCRALEE RRSQQGPP
//
